Maxim Group Initiates Coverage On cbdMD with Buy Rating, Announces Price Target of $3
Portfolio Pulse from Benzinga Newsdesk
Maxim Group analyst Anthony Vendetti has initiated coverage on cbdMD (AMEX:YCBD) with a Buy rating and a price target of $3.

October 05, 2023 | 3:39 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Maxim Group has initiated coverage on cbdMD with a Buy rating and a price target of $3.
The Buy rating and price target of $3 announced by Maxim Group for cbdMD indicates a positive outlook for the company. This could potentially attract investors and drive the stock price up in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100